These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18327030)

  • 21. [Molecular biology and immunohistochemical prognostic markers in head and neck squamous epithelial carcinomas].
    Schmidt M; Hoppe F
    Laryngorhinootologie; 2000 Dec; 79(12):719-29. PubMed ID: 11199454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma.
    Gunduz E; Gunduz M; Beder L; Nagatsuka H; Fukushima K; Sutcu R; Delibas N; Yamanaka N; Shimizu K; Nagai N
    Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):254-60. PubMed ID: 19289703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular metastases markers in head and neck squamous cell carcinoma: review of the literature.
    Cortesina G; Martone T
    Acta Otorhinolaryngol Ital; 2006 Dec; 26(6):317-25. PubMed ID: 17633150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The value of squamous cell carcinoma antigen in the prognostic evaluation, treatment monitoring and followup of patients with penile cancer.
    Zhu Y; Ye DW; Yao XD; Zhang SL; Dai B; Zhang HL; Shen YJ
    J Urol; 2008 Nov; 180(5):2019-23. PubMed ID: 18801542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53, epidermal growth factor receptor and proliferating cell nuclear antigen in laryngeal squamous cell carcinoma are not predictive markers for the effect of adjuvant radiotherapy.
    Jiang H; Yang BB
    Acta Otolaryngol; 2009 Jan; 129(1):101-7. PubMed ID: 18607952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skp2, p27kip1 and EGFR assessment in head and neck squamous cell carcinoma: prognostic implications.
    Carracedo DG; Astudillo A; Rodrigo JP; Suarez C; Gonzalez MV
    Oncol Rep; 2008 Sep; 20(3):589-95. PubMed ID: 18695910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular markers of head and neck squamous cell carcinoma: promising signs in need of prospective evaluation.
    Lothaire P; de Azambuja E; Dequanter D; Lalami Y; Sotiriou C; Andry G; Castro G; Awada A
    Head Neck; 2006 Mar; 28(3):256-69. PubMed ID: 16284973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience.
    Ivanov K; Kolev N; Tonev A; Nikolova G; Krasnaliev I; Softova E; Tonchev A
    Hepatogastroenterology; 2009; 56(89):94-8. PubMed ID: 19453036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular discrimination of multiple primary versus metastatic squamous cell cancers of the head/neck and lung.
    Mercer RR; Lucas NC; Simmons AN; Zander DS; Tsongalis GJ; Funkhouser WK; Coleman WB
    Exp Mol Pathol; 2009 Feb; 86(1):1-9. PubMed ID: 19094981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular introduction to head and neck cancer (HNSCC) carcinogenesis.
    Chin D; Boyle GM; Theile DR; Parsons PG; Coman WB
    Br J Plast Surg; 2004 Oct; 57(7):595-602. PubMed ID: 15380692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does surgical resection of pulmonary metastases of head and neck cancer improve survival?
    Winter H; Meimarakis G; Hoffmann G; Hummel M; Rüttinger D; Zilbauer A; Stelter K; Spelsberg F; Jauch KW; Hatz R; Löhe F
    Ann Surg Oncol; 2008 Oct; 15(10):2915-26. PubMed ID: 18648883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular markers for diagnosis and prognosis.
    Partridge M; Gaballah K; Huang X
    Cancer Metastasis Rev; 2005 Jan; 24(1):71-85. PubMed ID: 15785873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive factors of neck metastases in laryngeal squamous cell carcinoma. Towards an integrated clinico-molecular classification.
    Almadori G; Bussu F; Paludettii G
    Acta Otorhinolaryngol Ital; 2006 Dec; 26(6):326-34. PubMed ID: 17633151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of primary tumor volume after concurrent chemoradiation with daily low-dose cisplatin for advanced-stage head and neck carcinoma.
    Hoebers FJ; Pameijer FA; de Bois J; Heemsbergen W; Balm AJ; Schornagel JH; Rasch CR
    Head Neck; 2008 Sep; 30(9):1216-23. PubMed ID: 18642295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRP genetic polymorphism is associated with lymph node metastasis in thoracic esophageal squamous cell cancer.
    Motoyama S; Miura M; Hinai Y; Maruyama K; Usami S; Saito H; Minamiya Y; Satoh S; Murata K; Suzuki T; Ogawa J
    Ann Surg Oncol; 2009 Sep; 16(9):2479-85. PubMed ID: 19495883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Personalizing cancer care: updates on head and neck cancer.
    de Souza JA; Cohen EE
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1219-22. PubMed ID: 19761425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
    De Schutter H; Geeraerts H; Verbeken E; Nuyts S
    Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current status of biomarkers in head and neck cancer.
    Chang SS; Califano J
    J Surg Oncol; 2008 Jun; 97(8):640-3. PubMed ID: 18493942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological agents in head and neck cancer.
    Bossi P; Locati LD; Licitra L
    Expert Rev Anticancer Ther; 2007 Nov; 7(11):1643-50. PubMed ID: 18020930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.